Бикбов Б.Т., Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998 2011 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ. 2014; 16 (1)
Готье С.В., Мойсюк Я.Г., Хомяков С.М. Донорство и трансплантация органов в Российской Федерации. VI сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2014; 16 (2)
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604 612
KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013; 3 (1)
European Best Practice Guidelines for Haemodialysis (Part 1) Nephrol Dial Transplant (2002) 17 [Suppl 7]
European best practice guidelines on haemodialysis (Part 2) Nephrol Dial Transplant (2007) 22 [Suppl 2]:
National Kidney Foundation KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
National Kidney Foundation KDOQI Clinical Practice Guidelines for Vascular Access, Update 2006
Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20(3):645-654
Grooteman MP, van den Dorpel MA, Bots ML, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087-1096
Ok E, Asci G, Toz H, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28(1):192-202
Maduell F, Moreso F, Pons M, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487- 497.
Tattersall J et EUDIAL, Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013 ;28(3):542-550
Davenport A. Optimization of heparin anticoagulation for hemodialysis. Hemodial Int 2011;15 (suppl 1):43-48
Fischer KG. Essentials of anticoagulation in hemodialysis.Hemodial Int 2007;11:178-189
Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24(5):1574-1579
17. E.Movilli, P.Gaggia, R.Zubani et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. Nephrol Dial Transplant. 2007; 22: 3547 3552
18. Dialysate for hemodialysis ANSI/AAMI RD52:2004
19. Смирнов А.В., Нестерова О.Б., Суглобова Е.Д. с соавт. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх. 2013; 85 (1): 69-75
Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205-1213.
Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther. 1995;2(4):295-304.
Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial. 2001;14(4):252-256.
National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005
European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 1999;14 [Suppl 5]
Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 2004;19 [Suppl 2]
National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Supplements 2012; Vol 2, Issue 4, August (2)
National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease 2003
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease Mineral and Bone Disorder (CKD MBD) Kidney Int 2009 Vol 76, Suppl 113
National Kidney Foundation KDOQI Nutrition Guidelines American Journal of Kidney Diseases,Vol 35, No 6, Suppl 2, 2000: S1-S3
National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26:1948 1955
Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-658.
Robinson BM, Tong L, Zhang J et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2012;82(5):570-580